highlight / actuality
Researchers in our laboratory are developing copper chelators in its Cu(I) form in order to obtain the most effective active molecules possible for treating Wilson's disease. In collaboration, they have developed lipophilic versions encapsulated in lipidic nanovectors called lipidots, stable for several months..
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.